Changes in short-term (in-ICU and in-hospital) mortality following intensive care unit admission in adults living with HIV: 2000-2019.


Journal

AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219

Informations de publication

Date de publication:
15 11 2023
Historique:
medline: 26 10 2023
pubmed: 22 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

Limited data suggest intensive care unit (ICU) outcomes have improved in people with HIV (PWH). We describe trends in in-ICU/in-hospital mortality among PWH following admission to ICU in a single UK-based HIV referral centre, from 1 January 2000 to 31 December 2019. Modelling of associations between ICU admission and calendar year of admission was done using logistic regression with adjustment for age, sex, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, CD4 + T-cell count and diagnosis of HIV at/within the past 3 months. Among 221 PWH (71% male, median [interquartile range (IQR)] age 45 years [38-53]) admitted to ICU, median [IQR] APACHE II score and CD4 + T-cell count were 19 [14-25] and 122 cells/μl [30-297], respectively; HIV-1 viral load was ≤50 copies/ml in 46%. The most common ICU admission diagnosis was lower respiratory tract infection (30%). In-ICU and in-hospital, mortality were 29 and 38.5%, respectively. The odds of in-ICU mortality decreased over the 20-year period by 11% per year [odds ratio (OR): 0.89 (95% confidence interval (CI): 0.84-0.94)] with in-hospital mortality decreasing by 14% per year [0.86 (0.82-0.91)]. After adjusting for patient demographics and clinical factors, both estimates were attenuated, however, the odds of in-hospital mortality continued to decline over time [in-ICU mortality: adjusted OR: 0.97 (0.90-1.05); in-hospital mortality: 0.90 (0.84-0.97)]. Short-term mortality of critically ill PWH admitted to ICU has continued to decline in the ART era. This may result from changing indications for ICU admission, advances in critical care and improvements in HIV-related immune status.

Identifiants

pubmed: 37605448
doi: 10.1097/QAD.0000000000003683
pii: 00002030-990000000-00323
pmc: PMC10621640
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2169-2177

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Références

N Engl J Med. 2001 Nov 8;345(19):1368-77
pubmed: 11794169
PLoS One. 2017 Oct 24;12(10):e0186968
pubmed: 29065165
Am J Respir Crit Care Med. 1997 Jan;155(1):67-71
pubmed: 9001291
Thorax. 2008 Nov;63(11):988-93
pubmed: 18535118
Chest. 2000 Sep;118(3):704-11
pubmed: 10988192
Semin Respir Crit Care Med. 2016 Apr;37(2):303-17
pubmed: 26974306
J Public Health (Oxf). 2014 Dec;36(4):684-92
pubmed: 24323951
Chest. 2000 Jul;118(1):138-45
pubmed: 10893371
Medicine (Baltimore). 2022 Jul 15;101(28):e29750
pubmed: 35839058
PLoS Med. 2013;10(9):e1001510
pubmed: 24137103
J Crit Care. 2012 Feb;27(1):51-7
pubmed: 22033058
Intensive Care Med. 2020 Feb;46(2):329-342
pubmed: 32016535
Chest. 2009 Jan;135(1):11-17
pubmed: 18719058
Intensive Care Med. 2004 Apr;30(4):536-55
pubmed: 14997291
BMC Infect Dis. 2013 Jan 19;13:23
pubmed: 23331544
HIV Med. 2013 Nov;14(10):596-604
pubmed: 23672663
Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1305-10
pubmed: 7952557
Crit Care Med. 2009 May;37(5):1605-11
pubmed: 19325488
Lancet. 2010 Oct 16;376(9749):1354-61
pubmed: 20934211
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Arch Med Res. 2007 Nov;38(8):827-33
pubmed: 17923262
Thorax. 2007 Nov;62(11):964-8
pubmed: 17517829
J Infect. 2016 May;72(5):587-96
pubmed: 26920789
AIDS. 2003 Jan 3;17(1):73-80
pubmed: 12478071
J Intensive Care Soc. 2021 Feb;22(1):47-51
pubmed: 33643432
AIDS. 2021 Nov 15;35(14):2355-2365
pubmed: 34261095
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
Lancet Public Health. 2017 Jan;2(1):e35-e46
pubmed: 29249478
HIV Med. 2020 Nov;21(10):650-658
pubmed: 32876389
AIDS. 2006 Nov 28;20(18):2371-9
pubmed: 17117024
Chest. 1995 Feb;107(2):506-10
pubmed: 7842785
Eur J Clin Microbiol Infect Dis. 2011 Sep;30(9):1085-93
pubmed: 21331480
Ann Intensive Care. 2012 Jul 04;2(1):25
pubmed: 22762133
J Infect Dev Ctries. 2023 Jan 31;17(1):102-110
pubmed: 36795933
Crit Care. 2010;14(3):R107
pubmed: 20534139
Chest. 2020 Feb;157(2):293-309
pubmed: 31421114
PLoS One. 2020 Sep 21;15(9):e0239452
pubmed: 32956419
Arch Intern Med. 2000 Feb 28;160(4):541-7
pubmed: 10695695
Thorax. 2006 Aug;61(8):716-21
pubmed: 16601092
Lancet HIV. 2019 Aug;6(8):e540-e551
pubmed: 31285181
Int J STD AIDS. 2011 Sep;22(9):498-504
pubmed: 21890545
HIV Med. 2008 Jul;9(6):397-405
pubmed: 18410354
Int J STD AIDS. 2012 Oct;23(10):692-7
pubmed: 23104742
Am J Respir Crit Care Med. 2015 Jan 15;191(2):177-85
pubmed: 25478681
HIV Med. 2022 Dec;23(11):1163-1172
pubmed: 36404292

Auteurs

Tanmay Kanitkar (T)

Intensive Care Unit.
HIV Services, Royal Free Hospital, Royal Free London NHS Foundation Trust.

Oshani Dissanayake (O)

HIV Services, Royal Free Hospital, Royal Free London NHS Foundation Trust.

Nicholas Bakewell (N)

Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health.

Maggie Symonds (M)

HIV Services, Royal Free Hospital, Royal Free London NHS Foundation Trust.

Stephanie Rimmer (S)

Intensive Care Unit.

Amit Adlakha (A)

Intensive Care Unit.

Marc C I Lipman (MCI)

HIV Services, Royal Free Hospital, Royal Free London NHS Foundation Trust.
UCL Respiratory, Division of Medicine, University College London.
Respiratory Medicine, Royal Free Hospital, Royal Free London NHS Foundation Trust.

Sanjay Bhagani (S)

HIV Services, Royal Free Hospital, Royal Free London NHS Foundation Trust.

Caroline A Sabin (CA)

Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health.
National Institute for Health and Care Research (NIHR) Health Protection Research Unit (HPRU) in Blood Borne and Sexually Transmitted Infections.

Banwari Agarwal (B)

Intensive Care Unit.

Robert F Miller (RF)

HIV Services, Royal Free Hospital, Royal Free London NHS Foundation Trust.
Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH